Eyelid Crush for Marginal Eyelid Surgery
Outcome of Eyelid Crush for Intraoperative Hemostasis of Eyelid Margin Surgery
1 other identifier
observational
60
1 country
1
Brief Summary
Surgery involves eyelid margin asscocited with intraoperative bleeding. Proper intra-operative homeostasis is essential for good intraoperative procedure and postoperative results.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedFirst Submitted
Initial submission to the registry
February 3, 2020
CompletedFirst Posted
Study publicly available on registry
February 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2021
CompletedJanuary 27, 2021
January 1, 2021
2.2 years
February 3, 2020
January 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
amount of intraoperative bleeding
bleeding is recorded by photography
intraoperative
Secondary Outcomes (1)
time of operation
intraoperative
Study Arms (2)
Study group
Eyelid surgery involving eyelid margin is done after eyelid margin crushing with hemostat at start of surgery
Control group
Eyelid surgery involving eyelid margin is done after eyelid margin crushing without hemostat
Interventions
after marking eyelid , hemostat is used for eyelid margin incision crush . Then eyelid surgery is done
Eligibility Criteria
60 patient with marginal eyelid diseases surgeries will undergo surgeries
You may qualify if:
- All surgeries involving eyelid margin
You may not qualify if:
- bleeding tendency
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Benha Universitylead
Study Sites (1)
INMC
Abu Dhabi, 46266, United Arab Emirates
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
TAREK R ELHAMAKY, MD
Benha university faculty of medicine
Central Study Contacts
TAREK R ELHAMAKY
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer ophthalmology
Study Record Dates
First Submitted
February 3, 2020
First Posted
February 5, 2020
Study Start
January 1, 2019
Primary Completion
April 1, 2021
Study Completion
April 15, 2021
Last Updated
January 27, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share